VOLITIONRX LTD — Director's Dealing 2016

Mar 31, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2016-03-29

Reporting Person: Colman Alan (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-29	Common Stock	M	100000	$0.5	Acquired	153937	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-29	Warrant (Right to Buy)	$0.5	M	100000	Disposed	2016-04-01	Common Stock (100000)	Direct